Clinical trial
Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight…
NCT00463112 · Hippocration General Hospital, Other · Completed
Key facts
| NCT number | NCT00463112 |
|---|---|
| Title | Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS |
| Official title | Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS: a Randomized, 24-Week Study |
| Lead sponsor | Hippocration General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity, Polycystic Ovary Syndrome |
| Intervention type | Drug |
| Interventions | Sibutramine |
| Enrollment | 80 |
| Start date | Mar 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Apr 20, 2007 |
| Last update posted | Apr 20, 2007 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: